Patents Assigned to BioVaxys Inc.
  • Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
    Patent number: 12042537
    Abstract: The present disclosure provides methods, uses and compositions and kits for use in inducing an antibody immune response in a human subject. The methods and uses involve administering parenterally a low dose volume of a composition comprising an antigen comprising a B-cell epitope, an amphipathic compound, and a hydrophobic carrier, wherein the low dose volume of the composition is less than 100 ?l and induces an antibody immune response to the B-cell epitope in the human subject.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: July 23, 2024
    Assignee: BioVaxys Inc.
    Inventors: Marc Mansour, Frederic Ors, Marianne Stanford, Leeladhar Sammatur, Rajkannan Rajagopalan, Lisa Diana MacDonald